“…NCV and IENFD are known to decrease in patients with diabetes (Sveen et al, 2013). Similarly, several animal and human studies have correlated inflammation with neuropathy phenotype in diabetes (Duksal, Tiftikcioglu, Bilgin, Kose, & Zorlu, 2016; Paeschke et al, 2019; Zeng, Xu, Shi, & Jiang, 2018). Inflammatory cytokines, especially TNF‐α, modulate various signaling pathways including protein kinase C (Matsubara, Fuchimoto, & Orita, 1991), aldose reductase (Iwata et al, 1999) and 5′ adenosine monophosphate‐activated protein kinase (Tse et al, 2017), and all of which are known to play a vital role in the pathogenesis of diabetic neuropathy (Yamakawa et al, 2011).…”